Does 2022 already seem like a blur? The Pharma in Brief team is here for you with a summary of some of 2022’s most significant legal and regulatory developments in the Canadian pharmaceutical space. We also flag what to watch out for in 2023.    The most significant legislative changes concerned the Patent Act and accompanying rules/regulations. The Patented Medicine Prices Review Board (PMPRB) gained a new basket of comparator countries for international reference pricing…